Selecting the right site is the single most crucial decision you’ll make about your next clinical trial. And perhaps the single most important consideration in selecting a site is whether it can make its enrollment. Many don’t; in fact, 20-25…
Removing Barriers: Reimbursement and Compensation for Participation in Oncology Clinical Trials
It is an often-repeated statistic that only 3% -5% of patients with cancer participate in clinical trials for cancer therapies. The reasons for this are myriad. One survey found that only 16% of patients were aware of relevant clinical trials…
Small Biopharmas Face Unique Challenges Outsourcing Early-Stage Drug Development Issues
By partnering with external drug development service providers, small biopharmaceutical start-ups can move their products out of the lab and into clinical development more efficiently. At the forefront of the biopharmaceutical revolution are hundreds of small start-up companies with…
Are remote clinical trials cheaper?
In 2014, The Tufts Center for the Study of Drug Development estimated the cost of bringing a drug to market to be $2.6 billion.1 With such escalating costs and drug pricing discussions at an all-time high, many companies are exploring…
“Hey Alexa, find a Clinical Trial for me….”
In this age of smart phones, cloud-based voice helpers and all things “Google” the public and medical profession have many ways to find a clinical trial. The most comprehensive listing of clinical trials in the world can be found at…
CRAs are at risk of work-related mental health disorders
Clinical research associate (CRA) turnover has long been a complex and challenging issue. We can recruit more CRAs, increase publicity in colleges, and introduce assessment standards. I could quote various statistics regarding turnover, but I won’t. This article is not…
CROs Deliver Shorter Cycle Times, Says New Tufts Report
Contract research services are now the largest single cost category in pharma R&D spending, accounting for almost $90 billion last year, according to Tufts Center for the Study of Drug Development. All in, CROs raked in about $33 billion last…
Remotely Monitored Sites Must Maintain Vigilance and Communication, Expert Says
Multi-site trials rely on experienced remote monitors to coordinate their activities and communications, but that doesn’t mean the individual sites can slack off. The absence of face-to-face communication can magnify seemingly simple errors, a veteran trial monitor warns. Barbara Winter,…
Microsoft builds a bot to match patients to clinical trials
Patients, sometimes desperately sick, find it hard to comb through the roughly 50,000 clinical trials worldwide and their arcane and lengthy criteria. That’s where the the Clinical Trials Bot can help. A chat bot that began as a hackathon project at Microsoft’s…
Strength in numbers: Because having a rare disease isn’t rare
Rare doesn’t mean insignificant – in fact more people live with a rare disease than with cancer and AIDS combined. A decade after personal experience prompted her to found Global Genes, Nicole Boice tells Deep Dive that rare diseases need…
